| APOE in the bullseye of neurodegenerative diseases: Impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases R Fernández-Calle, SC Konings, J Frontiñán-Rubio, J García-Revilla, ... Molecular neurodegeneration 17 (1), 62, 2022 | 96 | 2022 |
| Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease A Boza-Serrano, A Vrillon, K Minta, A Paulus, L Camprubí-Ferrer, ... Acta neuropathologica 144 (5), 843-859, 2022 | 26 | 2022 |
| Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease J García-Revilla, A Boza-Serrano, Y Jin, DM Vadukul, J Soldán-Hidalgo, ... Acta Neuropathologica 146 (1), 51-75, 2023 | 10 | 2023 |
| LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer’s disease Y Yang, M García-Cruzado, H Zeng, L Camprubí-Ferrer, ... Brain, Behavior, and Immunity 113, 228-247, 2023 | 6 | 2023 |
| A mixture of Nordic berries improves cognitive function, metabolic function and alters the gut microbiota in C57Bl/6J male mice F Huang, N Marungruang, I Martinsson, L Camprubí Ferrer, TD Nguyen, ... Frontiers in Nutrition 10, 1257472, 2023 | | 2023 |
| GALECTIN-3 SHAPES TOXIC ALPHA-SYNUCLEIN AGGREGATES IN PARKINSON´ S DISEASE J Garcia-Revilla, A Boza-Serrano, Y Yin, D Vadukul, JS Hidalgo, ... IBRO Neuroscience Reports 15, S412, 2023 | | 2023 |
| GALECTIN-3 ROLE IN THE INTERACTION OF MICROGLIA AND AMYLOID-BETA IN VITRO L Camprubí-Ferrer, E Axell, R Fernández-Calle, J Frontiñan-Rubio, ... IBRO Neuroscience Reports 15, S375-S376, 2023 | | 2023 |
